# Grifols Therapeutics LLC

Canonical: https://abierto.us/vendors/grifols-therapeutics-llc-ufq3a7gkj5c7

- UEI: UFQ3A7GKJ5C7
- CAGE: 6SLC6
- Location: Research Triangle Park, NC
- Awards in window: 1 (2 transactions), $613,200 obligated, September 27, 2024 to August 6, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $613,200

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $613,200

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50124C00050 (definitive contract): $613,200, Barda - Aspr / Daappo / Barda DCMA. Grifols Therapeutics Llc- Ocular Surface Immunoglobulin in the Management of Vesicant Agents Injury. https://www.usaspending.gov/award/CONT_AWD_75A50124C00050_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/grifols-therapeutics-llc-ufq3a7gkj5c7.